Typhoid News and Research

RSS

Drug-resistant typhoid needs to be treated as a global problem

The bacteria that causes typhoid fever is becoming increasingly resistant to common antibiotics used to treat the disease, with resistant strains spreading to hundreds of countries in the past three decades, new analysis shows.

29 Jun 2022

Bacteria causing typhoid fever are highly developing antibiotic resistance

Bacteria causing Typhoid fever are becoming increasingly resistant to some of the most important antibiotics for human health, according to a study published in The Lancet Microbe journal. The largest genome analysis of Salmonella enterica serovar Typhi (S. Typhi) also reveals that resistant strains - almost all originating in South Asia - have spread to other countries nearly 200 times since 1990.

22 Jun 2022

Study estimates the global RSV disease burden in children under five in 2019

A new study published in The Lancet estimates that RSV-attributable acute lower respiratory infection was responsible for more than 100,000 deaths in children under five across the globe in 2019.

19 May 2022

IVI and partners to provide two doses of oral vaccine to 100,000 people at risk of cholera in Ethiopia

The International Vaccine Institute, in collaboration with LG Electronics, the Ethiopian government led by Armauer Hansen Research Institute, and the Ethiopian Public Health Institute, will vaccinate 40,000 people against cholera in May to support prevention of the disease in Ethiopia.

13 May 2022

SK bioscience's typhoid vaccine licensed for export by Korean Ministry of Food and Drug Safety

The International Vaccine Institute (IVI) and SK bioscience announced today that SK bioscience obtained an export license from the Korean Ministry of Food and Drug Safety for SK's typhoid vaccine 'SKYTyphoid' which they jointly developed.

12 May 2022

Moderate fitness levels produce significantly larger immune response in breast cancer survivors

A new study in breast cancer survivors has found that chemotherapy, while a critical part of breast cancer therapy, may also have some lasting dampening effects on natural immunity, but moderate fitness improvements can offer some protection against this effect.

26 Apr 2022

Phase I/II trials of new paratyphoid vaccine begin in Oxford

The University of Oxford in collaboration with the University of Maryland School of Medicine has begun recruiting for a Phase I/II trial of a new paratyphoid vaccine in human volunteers in Oxford - with first vaccinations taking place today (Tuesday).

26 Apr 2022

World Immunization Week 2022: Striving for a Long Life for All with the International Vaccine Institute

As part of World Immunization Week 2022, News Medical speaks to the International Vaccine Institute about their fight against vaccine inequity, as well as what a “Long Life for All” means to them.

25 Apr 2022

Impact of COVID-19 pandemic on vaccination campaigns for diseases preventable by vaccine

Researchers assess the influence of the COVID-19 pandemic on vaccine-preventable disease initiatives.

18 Apr 2022

Risk of myopericarditis following COVID-19 vaccination is very low, confirms study

The overall risk of myopericarditis following COVID-19 vaccination is very low, affecting 18 people per million vaccine doses. A new study published in The Lancet Respiratory Medicine, confirms that this risk is comparable to or lower following COVID-19 vaccination than other non-COVID-19 vaccines.

13 Apr 2022

Travel in the time of covid: Getting there is easy — It’s getting home that’s hard

I'm being held captive in England by the U.S. government. On the day my wife and I were to fly home from London after a brief visit, we took a covid-19 test, as required by the Centers for Disease Control and Prevention to travel to the U.S.

4 Apr 2022

New cholera vaccine generates long-lasting antibody responses in mice

Cholera, a diarrheal disease caused by the highly transmissible bacteria Vibrio cholerae, kills tens of thousands of people each year worldwide.

16 Feb 2022

Study assesses how vaccination against typhoid fever could help avert antimicrobial resistance

Researchers from Yale University, University of Basel, University of Antwerp, CDDEP and other institutions recently published 'Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modeling study' in The Lancet Infectious Diseases.

4 Feb 2022

Prevalence of menstrual changes following vaccination against COVID-19

A new study investigates the relationship between COVID-19 vaccination and menstrual cycle disturbances.

26 Nov 2021

Directly addressing falsehoods could help debunk health misinformation

With the world in the grip of a global pandemic, health misinformation has become a matter of life or death. But using audio dramas delivered on WhatsApp to explicitly address falsehoods could help Africa tackle this scourge, a study suggests.

24 Nov 2021

Study reveals ways to debunk highly prevalent health misinformation

The current pandemic shows how quickly health misinformation can spread. However, there are tools to debunk misinformation as demonstrated by a new study on health communication strategies from Karolinska Institutet in Sweden, published in the journal BMJ Global Health.

10 Nov 2021

Study finds menstrual bleeding changes after SARS-CoV-2 vaccination

A new study investigated menstrual bleeding patterns among current and former menstruating people, based on the premise that these bleeding changes were associated with changes in clotting or inflammation, which can affect the normal menstrual repair.

15 Oct 2021

Typhoid vaccine found to be 84% effective in preventing the disease in children

A vaccine has proved safe and effective in protecting children against typhoid, raising hopes of fighting the disease in Sub-Saharan Africa, a study says.

12 Oct 2021

Single dose of typhoid conjugate vaccine found to be safe and effective in Malawian kids

A new study, published today in the New England Journal of Medicine, finds a single dose of typhoid conjugate vaccine (TCV) – the only typhoid vaccine licensed for children as young as 6 months – is safe and 84 percent effective in protecting against typhoid in Blantyre, Malawi.

16 Sep 2021

CEPI and IVI announce new research program to expand access to COVID-19 vaccines in Africa

The Coalition for Epidemic Preparedness Innovations and the International Vaccine Institute today announced a new programme of clinical research which aims to expand access to COVID-19 vaccines in Africa.

20 Jul 2021